What Are the Symptoms of Skin Cancer?

Health & Lifestyle
345

Translate to Spanish or other 102 languages!

Talk to your doctor if you notice changes in your skin such as a new growth, a sore that doesn’t heal, a change in an old growth, or any of the A-B-C-D-Es of melanoma. Image for illustration purposes
Talk to your doctor if you notice changes in your skin such as a new growth, a sore that doesn’t heal, a change in an old growth, or any of the A-B-C-D-Es of melanoma. Image for illustration purposes

Mega Doctor News

- Advertisement -

CDC – A change in your skin is the most common sign of skin cancer. This could be a new growth, a sore that doesn’t heal, or a change in a mole Not all skin cancers look the same.

For melanoma specifically, a simple way to remember the warning signs is to remember the A-B-C-D-Es of melanoma—

  1. Asymmetrical: Does the mole or spot have an irregular shape with two parts that look very different?
  2. Border: Is the border irregular or jagged?
  3. Color: Is the color uneven?
  4. Diameter: Is the mole or spot larger than the size of a pea?
  5. Evolving: Has the mole or spot changed during the past few weeks or months?

Talk to your doctor if you notice changes in your skin such as a new growth, a sore that doesn’t heal, a change in an old growth, or any of the A-B-C-D-Es of melanoma.

- Advertisement -

More Information

Information Source:  CDC

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
What Is Skin Cancer?
Next article
Regenerative Medicine Research Lab to Open

More Articles

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

STHS GME Consortium Encourages Community to “Walk with a Doc”, June 6th

Mega Doctor News In an era defined by high-intensity workouts, wearable fitness trackers and advanced training techniques, one of simplest...

Study: Menopause Hormone Therapy Declines Nationwide Despite Proven Benefits

Hormone therapy use among women in the U.S. remains low, even though it's an effective treatment for many menopause symptoms, according to a new Mayo Clinic study published in Mayo Clinic Proceedings.
- Advertisement -